Our four-gene signature (CDC14A, PDK2, CHAD, and UGT2A3) exemplifies this approach by capturing key aspects of immune homeostasis and epithelial barrier function that are central to IBD pathophysiology. Here, UGT2A3 is linked to inflammatory bowel disease.